Skip to main content
Smart Investors Daily
VR

NASDAQ · VRAY

ViewRay, Inc.

Healthcare · Medical - Devices

$0.03

Up+$0.00 (+0.00%)

Updated Sep 10, 2026, 6:44 PM

SID Score

Composite research score

Smart Money

Institutional and insider signal

Market cap
4.56M
P/E ratio
-0.04
Dividend yield
0.00%
52-week range
— – —
Volume
96.17M
Avg. volume
96.17M

Price performance

VRAY price history

1M range · 0 trading sessions · Daily adjusted prices

VRAY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest VRAY news

The latest Smart Investors Daily articles mentioning VRAY.

VRAY research

Overview

Company profile and research snapshot.

Company profile

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. The company was founded in 2004 and is headquartered in Oakwood, Ohio.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
$6.25
Implied upside
Analysts
VRAY recent ratings
DateFirmRatingTarget
May 11, 2023B. Riley SecuritiesNeutral
May 11, 2023Morgan StanleyEqual-Weight
Apr 24, 2023Piper SandlerOverweight
Apr 17, 2023JefferiesHold
Apr 14, 2023Morgan StanleyEqual-Weight
Open full forecast

News briefing

No generated briefing is available yet.

Benzinga · Jul 24, 2023

Domino's Pizza, Whirlpool And 3 Stocks To Watch Heading Into Monday

With U.S. stock futures trading mixed this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Domino's Pizza, Inc. (NYSE: DPZ) to post quarterly earnings at $3.05 per share on revenue of $1.07 billion before the opening bell. Domino's shares gained 0.2% to $386.00 in after-hours trading. ViewRay, Inc. (NASDAQ: VRAY) reported commencement of Nasdaq delisting proceedings. The company’s common stock is ...

Benzinga · May 11, 2023

International Game Technology To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Thursday

Goldman Sachs raised the price target for Duolingo, Inc. (NASDAQ: DUOL) from $109 to $132. Goldman Sachs analyst Eric Sheridan maintained a Neutral rating. Duolingo shares rose 0.2% to $148.00 in pre-market trading. Keefe, Bruyette & Woods increased the price target for WisdomTree, Inc. (NYSE: WT) from $7 to $8. Keefe, Bruyette & Woods analyst Michael Brown maintained a Market Perform rating. Hain Celestial shares gained 1.7% to $6.68 in pre-market trading. Wells Fargo raised the price target for Ventas, Inc. (NYSE: VTR) from $50 to $53. Wells Fargo analyst Connor Siversky maintained an Overweight rating. Ventas shares rose 0.7% to $47.35 in pre-market trading. B. Riley Securities lowered ViewRay, Inc. (NASDAQ: VRAY) price target from $4 to $1. B. Riley ...

Zacks Investment Research · May 10, 2023

ViewRay (VRAY) Reports Q1 Loss, Misses Revenue Estimates

ViewRay (VRAY) delivered earnings and revenue surprises of -6.67% and 0.45%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research · May 9, 2023

Masimo (MASI) Beats Q1 Earnings and Revenue Estimates

Masimo (MASI) delivered earnings and revenue surprises of 4.82% and 1.38%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.